The total return over the past 12 months is +111.12% vs. +16.94% for the S&P 500. So far it's up -4.10% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +111.12% | (15.27%) | (20.56%) | N/A | N/A | N/A |
| Total Return CAGR | +111.12% | (15.27%) | (20.56%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Nautilus Biotechnolgy, Inc. (NAUT)
| Year | Start price | End price | NAUT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.95 | $1.87 | (4.10%) | +14.51% | (18.61%) |
| 2025 | $1.68 | $1.95 | +16.07% | +17.72% | (1.65%) |
| 2024 | $2.99 | $1.68 | (43.81%) | +24.89% | (68.70%) |
| 2023 | $1.80 | $2.99 | +66.11% | +26.19% | +39.92% |
| 2022 | $5.18 | $1.80 | (65.25%) | (18.17%) | (47.08%) |
| 2021 | $10.85 | $5.18 | (52.26%) | +28.74% | (81.00%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
